128 related articles for article (PubMed ID: 14676472)
1. A novel mutation identified in the DFNA5 gene in a Dutch family: a clinical and genetic evaluation.
Bischoff AM; Luijendijk MW; Huygen PL; van Duijnhoven G; De Leenheer EM; Oudesluijs GG; Van Laer L; Cremers FP; Cremers CW; Kremer H
Audiol Neurootol; 2004; 9(1):34-46. PubMed ID: 14676472
[TBL] [Abstract][Full Text] [Related]
2. A novel DFNA5 mutation, IVS8+4 A>G, in the splice donor site of intron 8 causes late-onset non-syndromic hearing loss in a Chinese family.
Cheng J; Han DY; Dai P; Sun HJ; Tao R; Sun Q; Yan D; Qin W; Wang HY; Ouyang XM; Yang SZ; Cao JY; Feng GY; Du LL; Zhang YZ; Zhai SQ; Yang WY; Liu XZ; He L; Yuan HJ
Clin Genet; 2007 Nov; 72(5):471-7. PubMed ID: 17868390
[TBL] [Abstract][Full Text] [Related]
3. Nonsyndromic hearing impairment is associated with a mutation in DFNA5.
Van Laer L; Huizing EH; Verstreken M; van Zuijlen D; Wauters JG; Bossuyt PJ; Van de Heyning P; McGuirt WT; Smith RJ; Willems PJ; Legan PK; Richardson GP; Van Camp G
Nat Genet; 1998 Oct; 20(2):194-7. PubMed ID: 9771715
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a founder mutation causing DFNA5 hearing loss in East Asians.
Park HJ; Cho HJ; Baek JI; Ben-Yosef T; Kwon TJ; Griffith AJ; Kim UK
J Hum Genet; 2010 Jan; 55(1):59-62. PubMed ID: 19911014
[TBL] [Abstract][Full Text] [Related]
5. A DFNA5 mutation identified in Japanese families with autosomal dominant hereditary hearing loss.
Nishio A; Noguchi Y; Sato T; Naruse TK; Kimura A; Takagi A; Kitamura K
Ann Hum Genet; 2014 Mar; 78(2):83-91. PubMed ID: 24506266
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin.
Wang Y; Gao W; Shi X; Ding J; Liu W; He H; Wang K; Shao F
Nature; 2017 Jul; 547(7661):99-103. PubMed ID: 28459430
[TBL] [Abstract][Full Text] [Related]
7. Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death.
Rogers C; Fernandes-Alnemri T; Mayes L; Alnemri D; Cingolani G; Alnemri ES
Nat Commun; 2017 Jan; 8():14128. PubMed ID: 28045099
[TBL] [Abstract][Full Text] [Related]
8. Exonic mutations and exon skipping: Lessons learned from DFNA5.
Booth KT; Azaiez H; Kahrizi K; Wang D; Zhang Y; Frees K; Nishimura C; Najmabadi H; Smith RJ
Hum Mutat; 2018 Mar; 39(3):433-440. PubMed ID: 29266521
[TBL] [Abstract][Full Text] [Related]
9. Pore-forming activity and structural autoinhibition of the gasdermin family.
Ding J; Wang K; Liu W; She Y; Sun Q; Shi J; Sun H; Wang DC; Shao F
Nature; 2016 Jul; 535(7610):111-6. PubMed ID: 27281216
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death.
Shi J; Zhao Y; Wang K; Shi X; Wang Y; Huang H; Zhuang Y; Cai T; Wang F; Shao F
Nature; 2015 Oct; 526(7575):660-5. PubMed ID: 26375003
[TBL] [Abstract][Full Text] [Related]
11. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation.
Rogers C; Erkes DA; Nardone A; Aplin AE; Fernandes-Alnemri T; Alnemri ES
Nat Commun; 2019 Apr; 10(1):1689. PubMed ID: 30976076
[TBL] [Abstract][Full Text] [Related]
12. The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage.
Masuda Y; Futamura M; Kamino H; Nakamura Y; Kitamura N; Ohnishi S; Miyamoto Y; Ichikawa H; Ohta T; Ohki M; Kiyono T; Egami H; Baba H; Arakawa H
J Hum Genet; 2006; 51(8):652-664. PubMed ID: 16897187
[TBL] [Abstract][Full Text] [Related]
13. Gasdermin E suppresses tumour growth by activating anti-tumour immunity.
Zhang Z; Zhang Y; Xia S; Kong Q; Li S; Liu X; Junqueira C; Meza-Sosa KF; Mok TMY; Ansara J; Sengupta S; Yao Y; Wu H; Lieberman J
Nature; 2020 Mar; 579(7799):415-420. PubMed ID: 32188940
[TBL] [Abstract][Full Text] [Related]
14. The deafness gene GSDME: its involvement in cell apoptosis, secondary necrosis, and cancers.
Li YQ; Peng JJ; Peng J; Luo XJ
Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1043-1048. PubMed ID: 31230091
[TBL] [Abstract][Full Text] [Related]
15. Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer.
Ibrahim J; Op de Beeck K; Fransen E; Croes L; Beyens M; Suls A; Vanden Berghe W; Peeters M; Van Camp G
Cancer Med; 2019 May; 8(5):2133-2145. PubMed ID: 30993897
[TBL] [Abstract][Full Text] [Related]
16. Molecular Targeted Therapies Elicit Concurrent Apoptotic and GSDME-Dependent Pyroptotic Tumor Cell Death.
Lu H; Zhang S; Wu J; Chen M; Cai MC; Fu Y; Li W; Wang J; Zhao X; Yu Z; Ma P; Zhuang G
Clin Cancer Res; 2018 Dec; 24(23):6066-6077. PubMed ID: 30061362
[TBL] [Abstract][Full Text] [Related]
17. A novel splice site mutation in DFNA5 causes late-onset progressive non-syndromic hearing loss in a Chinese family.
Chai Y; Chen D; Wang X; Wu H; Yang T
Int J Pediatr Otorhinolaryngol; 2014 Aug; 78(8):1265-8. PubMed ID: 24933359
[TBL] [Abstract][Full Text] [Related]
18. Methylation of the DFNA5 gene is frequently detected in colorectal cancer.
Yokomizo K; Harada Y; Kijima K; Shinmura K; Sakata M; Sakuraba K; Kitamura Y; Shirahata A; Goto T; Mizukami H; Saito M; Kigawa G; Nemoto H; Hibi K
Anticancer Res; 2012 Apr; 32(4):1319-22. PubMed ID: 22493364
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
